
Further FDA support for Parkinson’s gene therapy
AskBio’s investigational gene therapy AB-1005 for the treatment of Parkinson’s disease (PD) has been granted Regenerative Medicine Advanced Therapy (RMAT) designation by the US Food and Drug Administration (FDA). The FDA decision follows a review of information and data provided by AskBio, including clinical evidence from the open label Phase… Read More












